• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在通过金属螯合亲和色谱法纯化高纯度凝血因子IX过程中包膜病毒和非包膜病毒的去除与灭活

Removal and inactivation of enveloped and non-enveloped viruses during the purification of a high-purity factor IX by metal chelate affinity chromatography.

作者信息

Roberts P L, Walker C P, Feldman P A

机构信息

Bio Products Laboratory, Elstree, UK.

出版信息

Vox Sang. 1994;67 Suppl 1:69-71.

PMID:8091741
Abstract

Virus reduction during the copper chelate affinity chromatography stage used during the purification of a new high-purity factor IX (BPLs 9MC) has been investigated. Virus reduction for the enveloped virus Sindbis was 6.5 log, a value which included approximately 2 log of inactivation due to the use of an acidic wash buffer (pH 4.4) during chromatography. In the case of the non-enveloped hepatitis-A-like poliovirus, which is acid-resistant, the virus reduction value was 4.0 log and was exclusively due to physical virus removal during the chromatographic process.

摘要

对一种新型高纯度凝血因子IX(BPLs 9MC)纯化过程中使用的铜螯合亲和色谱阶段的病毒去除情况进行了研究。包膜病毒辛德毕斯病毒的病毒去除率为6.5对数,该数值包括在色谱过程中使用酸性洗涤缓冲液(pH 4.4)导致的约2对数的失活。对于耐酸的非包膜甲型肝炎样脊髓灰质炎病毒,病毒去除率为4.0对数,这完全是由于色谱过程中病毒的物理去除。

相似文献

1
Removal and inactivation of enveloped and non-enveloped viruses during the purification of a high-purity factor IX by metal chelate affinity chromatography.在通过金属螯合亲和色谱法纯化高纯度凝血因子IX过程中包膜病毒和非包膜病毒的去除与灭活
Vox Sang. 1994;67 Suppl 1:69-71.
2
Inactivation and clearance of viruses during the manufacture of high purity factor IX.高纯度凝血因子IX生产过程中病毒的灭活与清除
Biologicals. 2000 Sep;28(3):129-36. doi: 10.1006/biol.1999.0242.
3
Improvement of virus safety of an antihemophilc factor IX by virus filtration process.通过病毒过滤工艺提高抗血友病因子IX的病毒安全性
J Microbiol Biotechnol. 2008 Jul;18(7):1317-25.
4
Virus inactivation by protein denaturants used in affinity chromatography.亲和色谱中使用的蛋白质变性剂对病毒的灭活作用。
Biologicals. 2007 Oct;35(4):343-7. doi: 10.1016/j.biologicals.2007.02.005. Epub 2007 May 24.
5
Virus elimination during the recycling of chromatographic columns used during the manufacture of coagulation factors.
Biologicals. 2014 Jul;42(4):184-90. doi: 10.1016/j.biologicals.2014.06.003. Epub 2014 Jun 26.
6
Virus removal from factor IX by filtration: validation of the integrity test and effect of manufacturing process conditions.通过过滤从凝血因子IX中去除病毒:完整性测试的验证及生产工艺条件的影响
Biologicals. 2010 Mar;38(2):303-10. doi: 10.1016/j.biologicals.2009.12.006. Epub 2010 Jan 20.
7
Chromatographic removal of viruses from plasma derivatives.
Dev Biol Stand. 1993;81:199-209.
8
Large-scale preparation and biochemical characterization of a new high purity factor IX concentrate prepared by metal chelate affinity chromatography.
Blood Coagul Fibrinolysis. 1994 Dec;5(6):939-48. doi: 10.1097/00001721-199412000-00010.
9
The removal of model viruses, poliovirus type 1 and canine parvovirus, during the purification of human albumin using ion-exchange chromatographic procedures.
Biologicals. 1997 Dec;25(4):391-401. doi: 10.1006/biol.1997.0115.
10
Affinity chromatography to remove viruses during preparation of plasma derivatives.
Dev Biol Stand. 1993;81:191-7.

引用本文的文献

1
Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates.用于血浆来源的凝血因子浓缩物的病原体灭活和去除方法。
Transfusion. 2014 May;54(5):1406-17. doi: 10.1111/trf.12423. Epub 2013 Sep 30.